Trial intelligence / Profile preview

Oral propranolol plus oxytocin versus oxytocin alone for labor induction in nulliparous women with prolonged pregnancy

IRCT201105316575N3Phase 3Completed

Sponsor
Ilam University of Medical Sciences
Start
Sep 2008
Modality
Small Molecules, Recombinant Proteins and Enzymes, Peptides
Countries
1
01

Overview

Phase 3, open-label trial of propranolol and oxytocin in Pregnancy prolongation (2 arms), sponsored by Ilam University of Medical Sciences. Primary endpoints: Duration of labor and Type of delivery. Started Sep 2008; status: completed.

02

Drugs

propranololoxytocin
03

Conditions

Pregnancy prolongation

Beyond the preview

Go deeper on IRCT201105316575N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201105316575N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call